Esperion Therapeutics | Betriebsaufwand


Operating Expenses Veränderung
Abbvie ABBV:US $ 11288M 2467M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amarin AMRN:US 157.27M 34.34M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Cytokinetics CYTK:US $ 99.84M 18.14M
Daiichi Sankyo 4568:JP 245.94B 38.74B
Eli Lilly And LLY:US $ 5277.9M 127.8M
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Geron GERN:US $ 28.05M 749K
Halozyme Therapeutics HALO:US $ 118.3M 76.7M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Merk MRK:US $ 9666M 666M
Minerva Neurosciences NERV:US $ 6.97M 1.02M
Moderna Inc MRNA:US 2.3B 463M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Seattle Genetics SGEN:US $ 630.61M 71.1M
United Therapeutics UTHR:US $ 265.1M 89.5M
Vanda Pharmaceuticals VNDA:US $ 60.93M 6.93M



Esperion Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.